GMFG and glioblastoma: The recent identification of GMFG as a novel biomarker and potential drug target further expands the therapeutic landscape, with studies showing that small molecules like risperidone demonstrate promising interactions with GMFG, suggesting a new avenue for GBM treatment [102].